Bristol firm relocates with North West Fund cash

ANOTHER biomedical firm has been lured to the region with the prospect of investment cash from the North West Fund.

Bristol-based nicotine patch firm TTS Pharma has agreed to relocate to Liverpool after securing £550,000 from the North West Fund for Biomedical, managed by SPARK Impact.

It follows the decision by Sheffield-based Zilico to move to Manchester on the back of investment from the fund, which offers £50,000 to £1.5m in return for equity.

The investment in TTS is part of a larger round o... For the full story register now for free or login below...